Pharmaceuticals
Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.
Pharmaceuticals
Filters
Refine your search

Solvent/co-solvent for pharmaceutical injectable formulations. It has a strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing.Benefits:
- It maintains low level of endotoxins with the bioburden limits- BET/MLT
- Controlled metallic impurities
- Developed for…
TDS

Antioxidant for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
- DMF filed excipient - CDE # F20200000188
- All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
TDS

Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
- DMF filed excipient - CDE # F20200000188
- All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
TDS

Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20200000189
TDS

Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20200000189
TDS

Antioxidant and reducing agent used in injectable formulations. t is an excipient designed for solid and semi-solid dosage forms. Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20200000189
TDS

Excipient designed for solid and semi-solid dosage forms. Antioxidant and reducing agent developed for injectable formulations.Benefits:
- DMF Filed - CDE # F20200000189
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
TDS

Preservative specially developed for solid and semi-solid dosage forms.Benefits:
- White, odorless or almost odorless, hygroscopic, crystalline
- Insoluble in 6N acetic acid but dissolves in hydrochloric acid
TDS